Xenetic Biosciences, Inc. (XBIO) Social Stream
Xenetic Biosciences Inc (XBIO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering XBIO.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued August 13, 2021
The Trend in the Analyst Price Target
Over the past 27 weeks, XBIO's average price target has gone up $1.25.
XBIO reports an average of 110.49% for its upside potential over the past 26 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
XBIO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XBIO as an investment opportunity.
- XBIO has a higher number of analysts covering the stock than just about none of of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, Xenetic Biosciences Inc's variance in analysts' estimates is lower than just about 100% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, Xenetic Biosciences Inc's average analyst price target is higher than 5.11% of them.
- In terms of how Xenetic Biosciences Inc fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 79.62% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Xenetic Biosciences Inc are VLON, UNCY, and RNAZ.
Is XBIO a Buy, Hold or Sell? See the POWR Ratings now!